Split-dosed MiraLAX/Gatorade is an effective, safe, and tolerable option for bowel preparation in low-risk patients: A randomized controlled study

American Journal of Gastroenterology

Volumn 107, Issue 7, 2012, Pages 1036-1042

  Samarasena, Jason B ^a,b   Muthusamy, V Raman ^b   Jamal, M Mazen ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GATORADE PLUS MACROGOL 3350; GOLYTELY; LAXATIVE; MACROGOL 3350; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CELL COUNT; CLINICAL EFFECTIVENESS; COLON LAVAGE; COLONOSCOPY; CONTROLLED STUDY; DOSE RESPONSE; ELECTROLYTE BLOOD LEVEL; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPORTS DRINK;

ANALYSIS OF VARIANCE; CATHARTICS; COLONOSCOPY; ELECTROLYTES; FEMALE; HUMANS; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RISK ASSESSMENT; SINGLE-BLIND METHOD; SURFACE-ACTIVE AGENTS; TREATMENT OUTCOME;

EID: 84863725217     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.115     Document Type: Article

References (0)